361 related articles for article (PubMed ID: 31692779)
21. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome.
Muller FM; Dawe RS; Moseley H; Fleming CJ
Dermatol Surg; 2009 Sep; 35(9):1349-54. PubMed ID: 19500127
[TBL] [Abstract][Full Text] [Related]
22. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
[TBL] [Abstract][Full Text] [Related]
23. Optical coherence tomography for margin definition of basal cell carcinoma before micrographic surgery-recommendations regarding the marking and scanning technique.
De Carvalho N; Schuh S; Kindermann N; Kästle R; Holmes J; Welzel J
Skin Res Technol; 2018 Feb; 24(1):145-151. PubMed ID: 29057513
[TBL] [Abstract][Full Text] [Related]
24. Mohs micrographic surgery for facial skin cancer.
Vuyk HD; Lohuis PJ
Clin Otolaryngol Allied Sci; 2001 Aug; 26(4):265-73. PubMed ID: 11559334
[TBL] [Abstract][Full Text] [Related]
25. Favourable results of Mohs micrographic surgery for basal cell carcinoma.
Gniadecki R; Glud M; Mortensen K; Bang B; Biskup E; Omland SH
Dan Med J; 2015 Dec; 62(12):A5171. PubMed ID: 26621396
[TBL] [Abstract][Full Text] [Related]
26. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
27. Mohs moat: peripheral cutaneous margin clearance in a collaborative approach for aggressive and deeply invasive basal cell carcinoma.
Vance KK; Pytynia KB; Antony AK; Krunic AL
Australas J Dermatol; 2014 Aug; 55(3):198-200. PubMed ID: 23866002
[TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinoma of the vulva: treatment with Mohs micrographic surgery.
Sinha K; Abdul-Wahab A; Calonje E; Craythorne E; Lewis FM
Clin Exp Dermatol; 2019 Aug; 44(6):651-653. PubMed ID: 30618159
[TBL] [Abstract][Full Text] [Related]
29. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
Aoyagi S; Nouri K
Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
[TBL] [Abstract][Full Text] [Related]
30. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
31. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
33. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
[TBL] [Abstract][Full Text] [Related]
34. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
[TBL] [Abstract][Full Text] [Related]
35. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
36. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
37. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
38. [Application of Mohs microsurgery in nasal basal cell carcinoma].
Ma WY; Liu W; Li XZ; Ye P; Zhang LQ; Cai XL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 53(6):440-443. PubMed ID: 29902849
[No Abstract] [Full Text] [Related]
39. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
[TBL] [Abstract][Full Text] [Related]
40. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
